Global Apheresis Market Size By Type (Centrifugation, Membrane Filtration), By Application (Renal Diseases, Neurology), By Region, And Segment Forecasts, 2023 to 2032

The Global Apheresis Market was valued at USD 2.7 billion in 2023 and is expected to reach USD 5.6 billion by 2031, growing at a CAGR of 9.4% during the forecast period (2023–2031). The market is experiencing substantial growth driven by the rising prevalence of chronic diseases, increasing demand for blood component separation, and the growing application of apheresis procedures in both therapeutic and donor settings. Apheresis plays a critical role in managing conditions such as autoimmune diseases, blood disorders, and certain cancers, while also supporting plasma collection for immunoglobulin and vaccine production.

Drivers:

1. Increasing Prevalence of Chronic and Autoimmune Disorders:

Rising incidence of conditions such as leukemia, myasthenia gravis, and multiple sclerosis is significantly boosting the demand for therapeutic apheresis procedures.

2. Growing Demand for Blood Components:

As demand for plasma-derived therapies and specific blood components increases globally, apheresis is becoming the preferred method due to its efficiency in selectively extracting desired elements.

3. Expansion of Plasma Fractionation Industry:

The booming biopharmaceutical sector is propelling the need for source plasma, encouraging investments in plasma donation centers and apheresis equipment.

Restraints:

1. High Cost of Apheresis Devices and Procedures:

The high capital and operational costs associated with apheresis machines and consumables act as a barrier, particularly in low- and middle-income countries.

2. Risks and Side Effects Associated with Apheresis:

Potential side effects like hypotension, allergic reactions, and infection risk may limit wider acceptance of the therapy, especially in outpatient settings.

Opportunity:

1. Emerging Applications in Cell Therapy and Organ Transplants:

Apheresis is finding expanding roles in cellular therapy, stem cell harvesting, and pre-transplant desensitization, presenting lucrative growth opportunities.

2. Technological Advancements in Apheresis Devices:

Innovations in device automation, portability, and improved filtration technologies are expected to enhance procedural efficiency and safety, further fueling market growth.

Market by System Type Insights:

Centrifugal Apheresis Devices accounted for the largest share in 2023, owing to their widespread adoption in both therapeutic and donor applications due to high processing efficiency. However, Membrane Separation Devices are expected to witness the fastest growth, particularly in regions prioritizing gentler and more selective component separation technologies.

Market by End-use Insights:

Hospitals & Blood Donation Centers dominated the market in 2023, attributed to the rise in therapeutic procedures and blood component collection. Additionally, Research Institutes & Biotechnology Companies are emerging as high-growth end users due to increasing investment in cell therapy and plasma-based product development.

Market by Regional Insights:

North America held the largest market share in 2023, driven by advanced healthcare infrastructure, high awareness of therapeutic apheresis, and well-established blood collection networks. Meanwhile, Asia-Pacific is expected to witness the highest CAGR during the forecast period, due to rising healthcare expenditure, increasing prevalence of hematologic conditions, and expanding plasma collection operations in countries like China and India.

Competitive Scenario:

Key players in the Global Apheresis Market include Terumo BCT Inc., Haemonetics Corporation, Fresenius Kabi AG, Asahi Kasei Medical Co., Ltd., Cerus Corporation, Kawasumi Laboratories Inc., B. Braun Melsungen AG, Kaneka Corporation, and Medica S.p.A. These companies are focusing on new product development, regional expansion, and strategic collaborations to strengthen their position in the competitive landscape.

Scope of Work – Global Apheresis Market

Report Metric Details

Market Size (2023) USD 2.7 billion

Projected Market Size (2031) USD 5.6 billion

CAGR (2023–2031) 9.4%

Key Segments by System Type Centrifugal Apheresis Devices, Membrane Separation Devices

Key Segments by End-use Hospitals & Blood Donation Centers, Research Institutes & Biotechnology Companies

Leading Region North America

Key Players Terumo BCT Inc., Haemonetics Corporation, Fresenius Kabi AG, Asahi Kasei Medical Co., Ltd.

Market Drivers Rise in chronic diseases, demand for blood components, expansion in plasma therapeutics

Market Opportunities Growth in cell therapy, innovations in device technologies

Key Market Developments:

2023: Terumo BCT introduced a next-generation apheresis platform with enhanced automation and reduced procedure time for plasma and platelet collections.

2024: Haemonetics Corporation announced its partnership with a leading biopharma company to optimize plasma collection through AI-integrated apheresis systems.

2025: Fresenius Kabi expanded its apheresis device manufacturing facility in Europe to meet rising global demand and support clinical trials in regenerative medicine.

FAQs:

1. What is the current market size of the Global Apheresis Market?

The market was valued at USD 2.7 billion in 2023.

2. What is the major growth driver of the Global Apheresis Market?

Rising demand for blood components and growing prevalence of chronic and autoimmune diseases are major growth drivers.

3. Which is the largest region during the forecast period in the Global Apheresis Market?

North America holds the largest market share, driven by its advanced healthcare infrastructure and high adoption of apheresis procedures.

4. Which segment accounted for the largest market share in the Global Apheresis Market?

Centrifugal Apheresis Devices held the largest market share in 2023.

5. Who are the key market players in the Global Apheresis Market?

Leading companies include Terumo BCT Inc., Haemonetics Corporation, Fresenius Kabi AG, and Asahi Kasei Medical Co., Ltd.